Publications

Zappasodi R, Serganova I, Cohen IJ, Maeda M, Shindo M, Senbabaoglu Y, Watson MLJ, Leftin A, Maniyar R, Verma S et al..  2021.  CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours.. Nature. 591(7851):652-658.

Fucà G, Ambrosini M, Agnelli L, Brich S, Sgambelluri F, Mortarini R, Pupa SM, Magni M, Devizzi L, Matteucci P et al..  2021.  Fifteen-year follow-up of relapsed indolent non-Hodgkin lymphoma patients vaccinated with tumor-loaded dendritic cells.. J Immunother Cancer. 9(6)

Wang H, Franco F, Tsui Y-C, Xie X, Trefny MP, Zappasodi R, Mohmood SRaza, Fernández-García J, Tsai C-H, Schulze I et al..  2020.  CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors.. Nat Immunol. 21(3):298-308.

Kluger HM, Tawbi HA, Ascierto ML, Bowden M, Callahan MK, Cha E, Chen HX, Drake CG, Feltquate DM, Ferris RL et al..  2020.  Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce.. J Immunother Cancer. 8(1)